Placebo2
Placebo2 is an intervention with 5 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure
Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)
Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction Trial
Dietary Seaweed and Early Breast Cancer: A Randomized Trial
Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients
Clinical Trials (5)
Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure
Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)
Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction Trial
Dietary Seaweed and Early Breast Cancer: A Randomized Trial
Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5